Epilepsy surgery has long been a critical component in the management of drug-resis- tant epilepsy. Traditional surgical approaches, while effective, often entail significant invasiveness, presenting substantial challenges. Recent advancements in the field have steered the paradigm to- wards minimally invasive techniques, underpinned by enhanced pre-surgical assessments. Notewor- thy innovations in this realm include the use of Magnetoencephalography (MEG) for accurate localization of the epileptic focus and the adoption of less invasive strategies such as Stereotactic EEG. These technological strides have contributed to a notable reduction in surgical risks and have concurrently improved patient outcomes. Additionally, the advent of neuromodulation methods, namely Vagal Nerve Stimulation and Deep Brain Stimulation, has introduced efficacious alternative treatments, especially in scenarios where traditional resective surgeries are not feasible. The incor- poration of cutting-edge technologies like MR-Guided Laser Interstitial Thermal Therapy (MRLITT) further underscores the movement towards precision and minimal invasiveness in surgical proce- dures. Collectively, these advancements represent a significant leap forward in epilepsy surgery, markedly enhancing the safety and efficacy of interventions in drug-resistant epilepsy.